Please login to the form below

Not currently logged in
Email:
Password:

First time

MHRA division reaffirms its commitment to improving advertising standards in first annual report

The Medicines and Healthcare products Regulatory Agency's (MHRA) Advertising Standards Unit has published its first annual report, Promoting High Standards in Medicines Advertising Regulations.

The report meets the commitment given by the MHRA to the Health Select Committee as part of the government's response to the publication The Influence of the Pharmaceutical Industry and details the changes that have been made to accommodate new challenges.

As part of the changes, the unit wants to establish itself a centre of excellence for advertising standards, taking a strategic approach to improving advertising practice and complementing two of the agency's aim: public health protection and provision of authoritative information.

In addition, the unit will be working alongside other MHRA divisions: for the vetting of new active substances, advertising assessors will work with the Licensing Division; to ensure that serious cases where there is a potential breach of law can be referred for timely review, the unit will join forces with the MHRA Enforcement Group and, to improve the agency's transparency of decision-making and accountability to the public, the unit will collaborate with the Vigilance and Risk Management of Medicines Division.

For further information on the report, visit www.mhra.gov.uk

2nd September 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics